1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. California >
  7. Exelixis >
  8. M&A

Exelixis Mergers & Acquisitions

Exelixis M&A Summary

Exelixis has acquired 3 companies, including 1 in the last 5 years.

Exelixis’ largest acquisition to date was in 2021, when it acquired GamaMabs Pharma - AMHR2 Antibody Technology for $5M. Exelixis has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Exelixis

Exelixis, Inc.

1851 Harbor Bay Parkway,
Alameda, California 94502
United States,
(650) 837-7000
www.exelixis.com

All (3) Buy (3) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2021-05-04 GamaMabs Pharma - AMHR2 Antibody Technology · Life Science
Toulouse, France

GamaMabs Pharma's AMHR2 Antibody Technology provides the development of optimized antibodies targeting AMHR2 for the treatment of cancer.

5 Divestiture

Exelixis

GamaMabs Pharma


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal